A quiet but consequential shift took place this week inside one of the most influential medical organizations in the country, and it sent shockwaves through an activist ecosystem that has long relied on institutional silence. The American Society of Plastic Surgeons, representing roughly 11,000 surgeons nationwide, issued a position statement advising against sex-change surgeries for minors and recommending that such procedures be delayed until at least age 19. In doing so, ASPS became the first major U.S. medical organization to openly reject the ideological insistence that irreversible medical interventions for children are settled science.
The statement was striking not for its rhetoric, but for its restraint. ASPS grounded its conclusion in evidence, or more precisely, the lack of it. Citing its own August 2024 findings, the group reiterated that the evidence base for gender-related endocrine and surgical interventions remains low certainty, particularly when it comes to long-term mental health outcomes. Combined with emerging concerns about irreversible harm in a developmentally vulnerable population, the organization concluded that the risk–benefit ratio simply cannot be justified for children and adolescents.
BREAKING: American Society of Plastic Surgeons issues new position statement opposing “gender-affirming” surgeries in adolescents under the age of 19.
ASPS also acknowledges risks of endocrine interventions, poor guidelines, and inappropriate use of “autonomy” principle. pic.twitter.com/eliBc6WhKo
— Leor Sapir (@LeorSapir) February 3, 2026
ASPS pointed to the growing international reversal on this issue, particularly in Europe, alongside the U.K.’s Cass Review and a comprehensive HHS analysis. One of the most damning admissions in the statement is also the most obvious: clinicians currently have no reliable way to determine which children experiencing gender distress will persist into adulthood and which will naturally desist. Available evidence suggests many do, in fact, experience resolution or significant reduction of distress without medical intervention.
That uncertainty carries profound ethical weight. When spontaneous resolution is possible and irreversible harm is plausible, a precautionary approach is not political—it is foundational medical ethics. ASPS explicitly addressed activist appeals to “adolescent autonomy,” noting that autonomy does not obligate physicians to provide treatments unsupported by favorable evidence, especially when patients are minors whose decision-making capacities are still developing.
When the medical ethics textbooks of the future are written, they’ll look back on sex-rejecting procedures for minors the way we look back on lobotomies.
I applaud @ASPS_News for placing itself on the right side of history by opposing these dangerous, unscientific experiments. https://t.co/2i8H3SUivI
— DrOzCMS (@DrOzCMS) February 4, 2026
This marks a dramatic evolution from the group’s 2019 position, when ASPS opposed state restrictions and echoed claims that such surgeries improved mental health. That certainty has collapsed under scrutiny. The organization still opposes criminalization and favors professional self-regulation, but the message is clear: slogans have been replaced by data, and ideology by caution.
Federal officials praised the move. HHS Secretary Robert F. Kennedy Jr. called it a defense of sound science, while CMS Administrator Dr. Mehmet Oz compared the practice to future medical scandals that would be studied with disbelief. Their remarks came just days after a New York jury awarded $2 million to a detransitioner who underwent a double mastectomy at 16, finding her doctors liable for malpractice.
That verdict, believed to be the first of its kind, may signal what comes next. As former insiders like Jamie Reed have warned for years, this is not a matter of isolated regret but systemic failure driven by belief rather than evidence.
